ARTL (Artelo Biosciences) Institutional Ownership: 5.45% (As of Jun. 30, 2026)


ARTL Artelo Biosciences Inc ARTL
31 GF Score
Price $1.10
! 2 Warning Signs
View Full Analysis

What is Artelo Biosciences Institutional Ownership?

Artelo Biosciences ARTL +3.60% 31 Institutional Ownership is 5.45% as of Jun. 30, 2026. GuruFocus rates ARTL with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Artelo Biosciences's institutional ownership is 5.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Artelo Biosciences's Insider Ownership is 26.91%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Artelo Biosciences's Float Percentage Of Total Shares Outstanding is 99.83%.

Artelo Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Artelo Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artelo Biosciences Institutional Ownership Chart

Artelo Biosciences Historical Data

The historical data trend for Artelo Biosciences can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 3.23 1.44 1.44 1.44 0.67 0.21 0.76 1.02 1.23 0.24
ARTL
31GF Score
Artelo Biosciences Inc ARTL
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artelo Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.45% mean?
Artelo Biosciences (ARTL) has a Institutional Ownership of 5.45% as of Jun. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Artelo Biosciences and its competitors.
Is Artelo Biosciences' Institutional Ownership too high?
Artelo Biosciences' current Institutional Ownership is 5.45%. Overall, Artelo Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Artelo Biosciences' Institutional Ownership compare to REVB and MTNB?
Artelo Biosciences' Institutional Ownership of 5.45% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Artelo Biosciences and its competitors. Artelo Biosciences's current Institutional Ownership is 5.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artelo Biosciences stock overvalued right now?
Artelo Biosciences (ARTL) has a current Institutional Ownership of 5.45%. The current Institutional Ownership is 5.45%. Artelo Biosciences' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Artelo Biosciences (ARTL), the current Institutional Ownership is 5.45% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artelo Biosciences Business Description

Address 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
31GF Score

Get the complete analysis for ARTL

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.10
Price